Raymond James Financial Services Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-84,605
| Closed | -$347K | – | 3479 |
|
|
2022
Q1 | $347K | Sell |
84,605
-9,843
| -10% | -$35.7K | ﹤0.01% | 2612 |
|
|
2021
Q4 | $337K | Sell |
94,448
-1,255
| -1% | -$4.39K | ﹤0.01% | 2633 |
|
|
2021
Q3 | $348K | Buy |
95,703
+4,561
| +5% | +$18.4K | ﹤0.01% | 2593 |
|
|
2021
Q2 | $397K | Buy |
91,142
+2,004
| +2% | +$8.16K | ﹤0.01% | 2533 |
|
|
2021
Q1 | $366K | Sell |
89,138
-5,961
| -6% | -$25.8K | ﹤0.01% | 2499 |
|
|
2020
Q4 | $379K | Sell |
95,099
-113,251
| -54% | -$366K | ﹤0.01% | 2314 |
|
|
2020
Q3 | $563K | Sell |
208,350
-16,122
| -7% | -$44.6K | ﹤0.01% | 1890 |
|
|
2020
Q2 | $617K | Buy |
224,472
+9,895
| +5% | +$27.6K | ﹤0.01% | 1774 |
|
|
2020
Q1 | $506K | Buy |
214,577
+113,836
| +113% | +$387K | ﹤0.01% | 1547 |
|
|
2019
Q4 | $473K | Sell |
100,741
-18,499
| -16% | -$75.7K | ﹤0.01% | 2020 |
|
|
2019
Q3 | $399K | Buy |
119,240
+4,224
| +4% | +$13.9K | ﹤0.01% | 2046 |
|
|
2019
Q2 | $378K | Buy |
115,016
+11,880
| +12% | +$34.4K | ﹤0.01% | 2106 |
|
|
2019
Q1 | $313K | Sell |
103,136
-70,843
| -41% | -$230K | ﹤0.01% | 2214 |
|
|
2018
Q4 | $473K | Buy |
173,979
+40,365
| +30% | +$133K | ﹤0.01% | 1709 |
|
|
2018
Q3 | $449K | Sell |
133,614
-12,420
| -9% | -$38.4K | ﹤0.01% | 2001 |
|
|
2018
Q2 | $377K | Sell |
146,034
-2,012
| -1% | -$5.01K | ﹤0.01% | 2073 |
|
|
2018
Q1 | $326K | Sell |
148,046
-32,620
| -18% | -$73.4K | ﹤0.01% | 1985 |
|
|
2017
Q4 | $360K | Buy |
180,666
+46,766
| +35% | +$102K | ﹤0.01% | 1914 |
|
|
2017
Q3 | $434K | Buy |
133,900
+38,475
| +40% | +$119K | ﹤0.01% | 1801 |
|
|
2017
Q2 | $307K | Buy |
+95,425
| New | +$270K | ﹤0.01% | 1973 |
|
Other funds holding ATRS
Raymond James Financial Services Advisors's ATRS Position: Q2 2022 in Review
Raymond James Financial Services Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 84,605 shares — an estimated $347K sold.
Raymond James Financial Services Advisors first reported a position in ATRS in Q2 2017 and held it in 20 quarters. The position peaked at $617K in Q2 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Raymond James Financial Services Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Raymond James Financial Services Advisors sold 84,605 Antares Pharma, Inc. shares in Q2 2022, an estimated $347K.
- Raymond James Financial Services Advisors first reported a position in Antares Pharma, Inc. in Q2 2017 and held it in 20 quarters.
- Raymond James Financial Services Advisors's Antares Pharma, Inc. position peaked at $617K in Q2 2020.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.